European Archives - Page 341 of 1100 - European Medical Journal

EMJ Oncology 11 [Supplement 4] 2023

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…

The Importance of the Multidisciplinary Team in the Management of Patients with Endometrial Cancer: Interviews with Two Key Opinion Leaders

Endometrial cancer is one of the most common gynaecological cancers in high-income countries, and the incidence is rising significantly…

Live Webinar: How to Translate Science into Patient Care, Long Term Outcomes in Clinical Trials | 13th November 3:00 PM - 4:00 PM GMT

This webinar will explore the impact of long term outcomes in clinical trials on clinical decision making.

Live Webinar: Direct Impact of In-House Rapid Lung NGS on Cancer Patient Outcomes | 21 December 4:00-5:00 PM GMT

In this webinar, Francesco Passiglia, MD, Associate Professor of Medical Oncology. University of Turin will summarize the complex landscape of the NSCLC precision oncology biomarkers and treatments.

Sarcomas Unveiled: Advances in Rare Cancer Care

Brian Van Tine joins Jonathan to provide an overview of his clinical interest in soft tissue and bone sarcomas.

Editor's Pick: Diagnostic Evaluation of Hair Loss: A Narrative Review

This review provides a systematic approach for dermatologists to use in order to accurately diagnose hair loss disorders…

The Enduring Potential of Anti-TNF Therapies: Insights from UEG Week 2023

This News Feature explores the approaches for optimising anti-TNF therapies in gastroenterology, based on content delivered during UEG…

Editor's Pick: Chrono-nutrition and Type 2 Diabetes

Type 2 diabetes (T2D) is a persistent metabolic anarchy, described by hyperglycaemia resulting from defects in insulin secretion…

Use of Artificial Intelligence Improves Outcomes in Intracranial Haemorrhage

Researchers found that the rapid growth of AI use in healthcare and its improving ability in prioritising and triaging suspected findings leads to early therapeutic interventions, particularly in ICH cases.

Time to trade in the traditional marketing model?

The evolution of customer engagement in pharmaceutical industry according to Rick Hollis, Director of Business Excellence, Ipsen. Listen now!